The Pfizer-BioNTech coronavirus vaccine has been shown to be safe and highly effective in children ages 5 to 11 years, setting the stage for authorization in this group, possibly before the end of October.The Pfizer-BioNTech coronavirus vaccine has been shown to be safe and highly effective in children ages 5 to 11 years, setting the stage for authorization in this group, possibly before the end of October.Coronavirus (2019-nCoV), Vaccination and Immunization, Children and Childhood, Centers for Disease Control and Prevention, Food and Drug Administration, Pfizer IncRead More
